Funding Rounds
EverImmune

EverImmune Debt Financing (2023, $3M)

EverImmune

Developer of biotherapeutic products to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Debt Financing

Raised Amount: $3.70M

Investors